Craig Ramirez
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$2.1MFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $2.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 1, 2023 | NIH | SBIR Phase II A novel monobody-drug conjugate to treat mutant Ras multiple myeloma | $1.1M | TEZCAT Laboratories LLC |
| Sep 1, 2021 | NIH | STTR Phase I A novel monobody-drug conjugate to treat mutant KRas pancreatic cancer. | $609K | TEZCAT Laboratories LLC with NEW YORK UNIVERSITY SCHOOL OF MEDICINE |
| Jul 15, 2020 | NIH | STTR Phase I A novel monobody-drug conjugate to treat mutant Ras multiple myeloma | $400K | TEZCAT Laboratories LLC with NEW YORK UNIVERSITY SCHOOL OF MEDICINE |
Peer ranks
Federal funding#954
Awards as PI#822
Patents#273
Companies
- TEZCAT Laboratories LLCLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.